Thyroid hormone excess and bone--a clinical review

Area of Science:

• Endocrinology
• Bone Metabolism
• Pharmacology

Background:

• Emerging evidence suggests potential adverse effects of exogenous thyroid hormone on bone density.
• Clinicians require a clear perspective on thyroid hormone replacement therapy's impact on bone health.

Purpose of the Study:

• To review and synthesize existing literature on the relationship between thyroid hormone therapy and bone health.
• To characterize patient populations and study parameters influencing bone mineral density outcomes.
• To provide guidance for clinicians managing thyroid hormone replacement.

Main Methods:

• Systematic review of available literature on thyroid hormone therapy and bone.
• Characterization of study populations, considering factors like age, gender, menopausal status, and history of hyperthyroidism.
• Analysis of bone mineral density measurements, utilizing advanced techniques such as dual-energy x-ray absorptiometry.

Main Results:

• Bone mineral density measurements in patients on thyroxine therapy are comparable to control subjects.
• Long-term thyroxine therapy is considered safe for bone health when dosages are meticulously managed.
• Clinically significant bone disease is not a typical outcome of appropriate thyroxine treatment.

Conclusions:

• Careful dose monitoring is crucial for ensuring the safety of long-term thyroid hormone replacement therapy regarding bone health.
• Thyroid hormone therapy, when appropriately managed, does not pose a significant risk for developing clinically relevant bone disease.
• The available evidence supports the safety of carefully monitored thyroxine treatment for patients.